PathAI vs Recursion

TL;DR: PathAI focuses on diagnostic precision with FDA-cleared tools for analyzing pathology images and supporting biomarker development, backed by a large network of pathologists for validation. Recursion operates earlier in the drug development pipeline, running millions of automated wet lab experiments to generate massive biological datasets for discovering entirely new drug candidates. PathAI integrates into existing clinical workflows with an API-accessible platform, while Recursion is a closed, end-to-end discovery engine centered on its proprietary supercomputer and robotics infrastructure.